Phillip G. Febbo, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 16,749 shares at $42.89 ($728K) on 2026-09-04, disclosed to the SEC on 2026-09-04.
Scheduled sale ($728k) by Chief Scientific & Med Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.88 | 3,639 | $163K | 22.4% |
| 2 | $42.89 | 10,405 | $446K | 61.3% |
| 3 | $43.66 | 2,705 | $118K | 16.2% |
| Total | $43.45 avg | 16,749 | $728K | 100% |
| Filing → |
| VCYT | SELL | 2025-03-06 | $536K | — | Filing → |
| VCYT | SELL | 2024-12-06 | $347K | — | Filing → |
| ILMN | SELL | 2022-04-07 | $1.4M | — | Filing → |